Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Block for NOAF Prevention in Cardiac Surgery
NCT04472299Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Apr 2021
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in Atrial fibrillation (AFib), sponsored by University of Minnesota. Started Apr 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04472299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04472299.